Jeffrey A. Towbin

810 total papers · 84.3k total citations
495 papers, 45.4k citations indexed

About

Jeffrey A. Towbin is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Jeffrey A. Towbin has authored 495 papers receiving a total of 45.4k indexed citations (citations by other indexed papers that have themselves been cited), including 385 papers in Cardiology and Cardiovascular Medicine, 217 papers in Molecular Biology and 78 papers in Surgery. Recurrent topics in Jeffrey A. Towbin's work include Cardiomyopathy and Myosin Studies (195 papers), Cardiac electrophysiology and arrhythmias (106 papers) and Cardiovascular Effects of Exercise (101 papers). Jeffrey A. Towbin is often cited by papers focused on Cardiomyopathy and Myosin Studies (195 papers), Cardiac electrophysiology and arrhythmias (106 papers) and Cardiovascular Effects of Exercise (101 papers). Jeffrey A. Towbin collaborates with scholars based in United States, Italy and Japan. Jeffrey A. Towbin's co-authors include Neil E. Bowles, Christine E. Seidman, Barry J. Maron, Charles Antzelevitch, John L. Jefferies, Silvia G. Priori, Mark T. Keating, Peter J. Schwartz, Josép Brugada and Arthur J. Moss and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

Jeffrey A. Towbin

487 papers receiving 43.9k citations

Hit Papers

Contemporary Definitions ... 1995 2026 2005 2015 2006 2011 1998 1995 2000 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Contemporary Definitions and Classification of the Cardiomyopathies
    2006 2.2k citations Barry J. Maron, Jeffrey A. Towbin et al. Circulation profile →
  2. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
    2011 1.6k citations Bernard J. Gersh, Barry J. Maron et al. Circulation profile →
  3. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation
    1998 1.3k citations Qiuyun Chen, Glenn E. Kirsch et al. Nature profile →
  4. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome
    1995 1.2k citations Qing Wang, Jiaxiang Shen et al. Cell profile →
  5. Spectrum of Mutations in Long-QT Syndrome Genes
    2000 958 citations Igor Splawski, Jiaxiang Shen et al. Circulation profile →
  6. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
    2011 868 citations Bernard J. Gersh, Barry J. Maron et al. Journal of the American College of Cardiology profile →
  7. The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease
    2007 692 citations Leslie T. Cooper, Kenneth L. Baughman et al. Circulation profile →
  8. Incidence, Causes, and Outcomes of Dilated Cardiomyopathy in Children
    2006 645 citations Jeffrey A. Towbin, April M. Lowe et al. JAMA profile →
  9. Long QT Syndrome Patients With Mutations of the SCN5A and HERG Genes Have Differential Responses to Na + Channel Blockade and to Increases in Heart Rate
    1995 583 citations Peter J. Schwartz, Silvia G. Priori et al. Circulation profile →
  10. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary
    2011 583 citations Bernard J. Gersh, Barry J. Maron et al. Circulation profile →
  11. Proposed Diagnostic Criteria for the Brugada Syndrome
    2002 558 citations Arthur A.M. Wilde, Charles Antzelevitch et al. Circulation profile →
  12. Effectiveness and Limitations of β-Blocker Therapy in Congenital Long-QT Syndrome
    2000 556 citations Arthur J. Moss, Wojciech Zaręba et al. Circulation profile →
  13. Sodium Channel Blockers Identify Risk for Sudden Death in Patients With ST-Segment Elevation and Right Bundle Branch Block but Structurally Normal Hearts
    2000 540 citations Ramón Brugada, Josép Brugada et al. Circulation profile →
  14. The Incidence of Pediatric Cardiomyopathy in Two Regions of the United States
    2003 538 citations Steven E. Lipshultz, Lynn A. Sleeper et al. New England Journal of Medicine profile →
  15. Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association
    2016 530 citations Biykem Bozkurt, Leslie T. Cooper et al. Circulation profile →
  16. Influence of the Genotype on the Clinical Course of the Long-QT Syndrome
    1998 504 citations Wojciech Zaręba, Arthur J. Moss et al. New England Journal of Medicine profile →
  17. Genetic Evaluation of Cardiomyopathy—A Heart Failure Society of America Practice Guideline
    2009 491 citations Ray E. Hershberger, JoAnn Lindenfeld et al. Journal of Cardiac Failure profile →
  18. Left ventricular non-compaction cardiomyopathy
    2015 299 citations Jeffrey A. Towbin, Angela Lorts et al. The Lancet profile →
  19. Diagnosis and Evaluation of Hypertrophic Cardiomyopathy
    2022 238 citations Barry J. Maron, Milind Y. Desai et al. Journal of the American College of Cardiology profile →
  20. Management of Hypertrophic Cardiomyopathy
    2022 179 citations Barry J. Maron, Milind Y. Desai et al. Journal of the American College of Cardiology profile →
  21. Diagnosis and Management of Myocarditis in Children
    2021 173 citations Yuk M. Law, Ashwin K. Lal et al. Circulation profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jeffrey A. Towbin 36.4k 19.6k 5.7k 5.4k 2.2k 495 45.4k
Christine E. Seidman 28.0k 0.8× 24.1k 1.2× 4.0k 0.7× 5.2k 1.0× 1.6k 0.7× 416 45.4k
Issei Komuro 16.7k 0.5× 20.5k 1.0× 6.8k 1.2× 3.9k 0.7× 3.5k 1.6× 1.2k 42.7k
Douglas L. Mann 23.0k 0.6× 11.6k 0.6× 6.8k 1.2× 3.7k 0.7× 2.4k 1.1× 451 39.1k
Masatsugu Hori 11.3k 0.3× 10.7k 0.5× 5.4k 0.9× 4.0k 0.7× 2.2k 1.0× 536 33.2k
Ryozo Nagai 11.3k 0.3× 18.1k 0.9× 7.4k 1.3× 8.8k 1.6× 3.9k 1.8× 859 45.4k
Stephen E. Epstein 28.6k 0.8× 8.0k 0.4× 11.0k 1.9× 6.0k 1.1× 3.7k 1.7× 526 46.2k
Joseph A. Hill 10.4k 0.3× 23.2k 1.2× 5.1k 0.9× 6.5k 1.2× 1.6k 0.8× 352 39.6k
Kenneth Walsh 9.8k 0.3× 28.2k 1.4× 7.2k 1.3× 11.1k 2.1× 2.8k 1.3× 460 53.8k
Roger J. Hajjar 14.6k 0.4× 17.4k 0.9× 4.3k 0.7× 1.5k 0.3× 1.3k 0.6× 500 28.8k
Toshio Ogihara 9.7k 0.3× 10.2k 0.5× 6.3k 1.1× 3.1k 0.6× 2.1k 1.0× 893 31.9k

Countries citing papers authored by Jeffrey A. Towbin

Since Specialization
Citations

This map shows the geographic impact of Jeffrey A. Towbin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey A. Towbin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey A. Towbin more than expected).

Fields of papers citing papers by Jeffrey A. Towbin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey A. Towbin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey A. Towbin. The network helps show where Jeffrey A. Towbin may publish in the future.

Co-authorship network of co-authors of Jeffrey A. Towbin

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey A. Towbin. A scholar is included among the top collaborators of Jeffrey A. Towbin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey A. Towbin. Jeffrey A. Towbin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gary Williamson Breakdown of academic impact, for papers by Shuquan Liang Breakdown of academic impact, for papers by Reisa A. Sperling Breakdown of academic impact, for papers by Yonggang Huang Breakdown of academic impact, for papers by Ian H. Gotlib Breakdown of academic impact, for papers by Keith T. Flaherty Breakdown of academic impact, for papers by Robert H. Purcell Breakdown of academic impact, for papers by Andrew K. Burroughs
Rankless by CCL
2026